Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (19)

2024

  1. A mammalian-specific Alex3/Gαq protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival

    Science Signaling, Vol. 17, Núm. 822

  2. Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation

    Brain, Vol. 147, Núm. 5, pp. 1899-1913

2022

  1. Defects of Nutrient Signaling and Autophagy in Neurodegeneration

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. A multicentre validation study of the diagnostic value of plasma neurofilament light

    Nature Communications, Vol. 12, Núm. 1

  2. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278

  3. The skeletal muscle emerges as a new disease target in amyotrophic lateral sclerosis

    Journal of Personalized Medicine, Vol. 11, Núm. 7

2020

  1. A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262

2019

  1. Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach

    Neural Regeneration Research, Vol. 14, Núm. 2, pp. 193-196

  2. Neuronal p38α mediates age-associated neural stem cell exhaustion and cognitive decline

    Aging Cell, Vol. 18, Núm. 6

2018

  1. Adrenomedullin, a Novel Target for Neurodegenerative Diseases

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 8799-8814

  2. Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis

    Journal of the Neurological Sciences

  3. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

  4. Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice

    Scientific Reports, Vol. 8, Núm. 1

  5. Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 9328-9333

  6. Retinoids and amyotrophic lateral sclerosis

    JAMA Neurology

2017

  1. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis

    Expert Reviews in Molecular Medicine, Vol. 19

  2. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001

2016

  1. ALS: A bucket of genes, environment, metabolism and unknown ingredients

    Progress in Neurobiology, Vol. 142, pp. 104-129